MicroRNA-506-3p inhibits colorectal cancer cell proliferation through targeting enhancer of zeste homologue 2

References

• Brody H. Colorectal cancer. Nature. 2015;521(7551):S1.
   PubMed Web of Science ®Google Scholar
• Weinberg BA, Marshall JL, Salem ME. The growing challenge of young adults with colorectal cancer. Oncology (Williston Park). 2017;31:381–389.
   PubMed Web of Science ®Google Scholar
• Roncucci L, Mariani F. Prevention of colorectal cancer: how many tools do we have in our basket? Eur J Intern Med. 2015;26(10):752–756.
   PubMed Web of Science ®Google Scholar
• Gbolahan O, O’Neil B. Update on systemic therapy for colorectal cancer: biologics take sides. Transl Gastroenterol Hepatol. 2019;4: 9.
   Google Scholar
• Li XW, Qiu SJ, Zhang X. Overexpression of miR-215-3p sensitizes colorectal cancer to 5-fluorouracil induced apoptosis through regulating CXCR1. Eur Rev Med Pharmacol Sci. 2018;22:7240–7250.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: a systematic review. Medicine (Baltimore). 2017;96(40):e8242.
   PubMed Web of Science ®Google Scholar
• Biller LH, Diagnosis SD. Treatment of Metastatic Colorectal Cancer: a Review. Jama. 2021;325(7):669–685.
   PubMed Web of Science ®Google Scholar
• Mei XL, Zheng QF. Role of Cellular Biomolecules in Screening, Diagnosis and Treatment of Colorectal Cancer. Curr Drug Metab. 2019;20(11):880–888.
   PubMed Web of Science ®Google Scholar
• Jung G, Hernández-Illán E, Moreira L, et al. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Clin Pract Gastroenterol Hepatol. 2020;17(2):111–130.
   Google Scholar
• Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, et al. MiR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017;23(17):5255–5266.
   PubMed Web of Science ®Google Scholar
• Jiang H, Deng R, Yang X, et al. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat Chem Biol. 2017;13(9):994–1001.
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–531.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233.
   PubMed Web of Science ®Google Scholar
• Seitz H. Redefining microRNA targets. Curr Biol. 2009;19(10):870–873.
   PubMed Web of Science ®Google Scholar
• Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36.
   PubMed Web of Science ®Google Scholar
• Li X, Chen R, Li Z, et al. Diagnostic Value of Combining miRNAs, CEA Measurement and the FOBT in Colorectal Cancer Screening. Cancer Manag Res. 2020;12.
   Web of Science ®Google Scholar
• Qiao PF, Yao L, Zeng ZL. Catalpol-mediated microRNA-34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer. Oncol Rep. 2020. DOI:10.3892/or.2020.7494
   Web of Science ®Google Scholar
• Zhao Z, Shelton SD, Oviedo A, et al. PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression. J Exp Clin Cancer Res. 2020;39(1):1.
   PubMed Web of Science ®Google Scholar
• Li H, Li T, Huang D, et al. Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway. Cancer Cell Int. 2020;20.
   PubMed Web of Science ®Google Scholar
• Xia XY, Yu YJ, Ye F, et al. MicroRNA-506-3p inhibits proliferation and promotes apoptosis in ovarian cancer cell via targeting SIRT1/AKT/FOXO3a signaling pathway. Neoplasma 2020;67(2):2.
   Web of Science ®Google Scholar
• Vire E, Brenner C, Deplus R, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871–874.
   PubMed Web of Science ®Google Scholar
• Bachmann IM, Halvorsen OJ, Collett K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol. 2006;24(2):268–273.
   PubMed Web of Science ®Google Scholar
• Wu X, Zhu H, Xie Y, et al. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer. 2020;25:1. J BUON..
   Google Scholar
• Zhang M, Duan W, LncRNA SW. SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis. Oncol Targets Ther. 2019;12.
   Google Scholar
• Shi L, Hong X, Ba L, et al. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression. Cell Death Dis. 2019;10(3):3.
   Google Scholar
• Xu M, Chen X, Lin K, et al. lncRNA SNHG6 regulates EZH2 expression by sponging miR-26a/b and miR-214 in colorectal cancer. J Hematol Oncol. 2019;12(1):1.
   PubMedGoogle Scholar
• Jiang M, Xu B, Li X, et al. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit. Oncogene. 2019;38:3.
   Web of Science ®Google Scholar
• Hong W, Xue M, Jiang J, et al. RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). J Exp Clin Cancer Res. 2020;39(1):149.
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhang H, Zhang J, et al. miR-210-3p Promotes Lung Cancer Development and Progression by Modulating USF1 and PCGF3. Onco Targets Ther. 2021;14:3687–3700.
   PubMed Web of Science ®Google Scholar
• Wang R, Sun Y, Yu W, et al. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT. J Exp Clin Cancer Res. 2019;38(1):20.
   PubMedGoogle Scholar
• Gbolahan O, O’Neil B. Update on systemic therapy for colorectal cancer: biologics take sides. 2019;4:9. Transl Gastroenterol Hepatol..
   Google Scholar
• Zhang Y, Chen Z, Li J. The current status of treatment for colorectal cancer in China: a systematic review. Medicine (Baltimore). 2017;96(40):e8242.
   PubMed Web of Science ®Google Scholar
• Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, et al. MiR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017;23(17):5255–5266.
   PubMed Web of Science ®Google Scholar
• Jiang H, Deng R, Yang X, et al. Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration. Nat Chem Biol. 2017;13(9):994–1001.
   PubMed Web of Science ®Google Scholar
• Tutar L, Özgür A, Tutar Y. Involvement of miRNAs and pseudogenes in cancer. Methods Mol Biol. 2018;1699:45–66.
   PubMedGoogle Scholar
• Ganju A, Khan S, Hafeez BB, et al. MiRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):424–432.
   PubMed Web of Science ®Google Scholar
• Bandini E, Fanini F. MicroRNAs and androgen receptor: emerging players in breast cancer. Front Genet. 2019;10:203.
   PubMed Web of Science ®Google Scholar
• Filipow S, Laczmanski L. Blood circulating miRNAs as cancer biomarkers for diagnosis and surgical treatment response. Front Genet. 2019;10:169.
   PubMed Web of Science ®Google Scholar
• Cammas A, Millevoi S. RNA G-quadruplexes:emerging mechanisms in disease. Nucleic Acids Res. 2017;45:1584–1595.
   PubMed Web of Science ®Google Scholar
• Zhang C, Bai G, Zhu W, et al. Identification of miRNA-mRNA network associated with acute myeloid leukemia survival. Med Sci Monit. 2017;23:4705–4714.
   PubMed Web of Science ®Google Scholar
• Pardini B, Calin GA. MicroRNAs and long non-coding RNAs and their hormone-like activities in cancer. Cancers (Basel). 2019;11(3):E378.
   PubMed Web of Science ®Google Scholar
• Li C, Lin X, Zhang C, et al. Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis. Hum Cell. 2021;34(4):1255–1265.
   PubMed Web of Science ®Google Scholar
• Hu Y, Sun H, Hu J, et al. LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p. Cancer Manag Res. 2020;12:7451–7463.
   PubMed Web of Science ®Google Scholar
• Zhou M, Dong Z, Hu S, et al. LINC01433 targets miR-506-3p to promote the biological progress of nasopharyngeal carcinoma cells. European archives of oto-rhino-laryngology: official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS): affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2021.
   Google Scholar
• Gong X, Li W, Dong L, et al. 2 promotes SEMA6D expression to enhance the cisplatin resistance in osteosarcoma through sponging miR-506-3p by activating Wnt/β-catenin signaling pathway. J Mol Histol. 2020;51(4):329–340.
   PubMed Web of Science ®Google Scholar
• Shi Z, Shen C, Yu C, et al. Long non-coding RNA LINC00997 silencing inhibits the progression and metastasis of colorectal cancer by sponging miR-512-3p. Bioengineered. 2021;12(1):627–639.
   PubMed Web of Science ®Google Scholar
• First EZH. 2 inhibitor approved-for rare sarcoma. Cancer Discov. 2020.
   Web of Science ®Google Scholar
• Stazi G, Taglieri L, Nicolai A, et al. Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: efects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-infammatory phenotype. Clin Epigenet. 2019;11(1):1–7.
   PubMed Web of Science ®Google Scholar
• Zhou L, Mudianto T, Ma X, et al. EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer. Clin Cancer Res. 2020;26(1):290–300.
   PubMed Web of Science ®Google Scholar
• Puppe J, Opdam M, Schouten PC, et al. EZH2 is overexpressed in BRCA1-like breast tumors and predictive for sensitivity to high-dose platinum-based chemotherapy. Clin Cancer Res. 2019;25(14):4351–4362.
   PubMed Web of Science ®Google Scholar
• Hong S, Li S, Bi M, et al. lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2. Mol Ther Nucleic Acids. 2021;24:1012–1023.
   PubMedGoogle Scholar
• Deng X, Kong F, Li S, et al. A KLF4/PiHL/EZH2/HMGA2 regulatory axis and its function in promoting oxaliplatin-resistance of colorectal cancer. Cell Death Dis. 2021;12(5):485.
   PubMed Web of Science ®Google Scholar
• Ma X, Lv L, Circ_ XC. 0115744 acts as miR-144 sponge to promote and predict the metastasis of colorectal cancer. Aging (Albany NY). 2021;13(4):5892–5905.
   PubMedGoogle Scholar
• Liu RJ, Li SY, Liu LQ, et al. Identification of biomarkers, pathways and potential therapeutic target for docetaxel resistant prostate cancer. Bioengineered. 2021;12(1):2377–2388.
   PubMed Web of Science ®Google Scholar
• Tan J, Yang X, Zhuang L, et al. Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 2007;21(9):1050–1063.
   PubMed Web of Science ®Google Scholar
• Kim KH, Kim W, Howard TP, et al. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2. Nat Med. 2015;21(12):1491–1496.
   PubMed Web of Science ®Google Scholar